{'fraction_non_alphanumeric': 0.019083969465648856, 'fraction_numerical': 0.0, 'mean_word_length': 5.907894736842105, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Expression of androgen receptor in inflammatory breast cancer and its clinical relevance

Inflammatory breast cancer (IBC) is characterized by an aggressive clinical course with early metastasis and frequent resistance to conventional therapies. Identifying a novel therapeutic approach may improve the prognosis for patients with IBC. Because androgen receptor (AR)‐expressing tumors may be targeted by anti‐AR therapy, the authors examined the prevalence of AR expression in IBC tumors and explored its clinical relevance.